SuperworthC4 Therapeutics market cap CCCC
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $376.5M
- Highest close in our data
- $2.4B
- Sep 2021
C4 Therapeutics is worth $376.5M at the close on Oct 23, 2026, at $3.06 a share.
That is up 116% over the last year and down 83% over five years.
Its highest close in our data was $2.4B in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $376.5M | $176.4M | $521.6M | +83% |
| 2025 | $205.5M | $88M | $278.1M | −23% |
| 2024 | $267.5M | $264.6M | $754.6M | −4% |
| 2023 | $278.4M | $64.1M | $418.1M | −4% |
| 2022 | $288.8M | $262M | $1.3B | −82% |
| 2021 | $1.6B | $1.3B | $2.4B | +10% |
| 2020 | $1.4B | $1.1B | $1.5B | n/a |
Against its peers
Companies in Biotechnology nearest C4 Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CCCCC4 Therapeutics | $376.5M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on C4 Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.